TissGeneSummary for EREG |
Gene summary |
Basic gene information | Gene symbol | EREG |
Gene name | epiregulin | |
Synonyms | ER | |
Cytomap | UCSC genome browser: 4q13.3 | |
Type of gene | protein-coding | |
RefGenes | NM_001432.2, | |
Description | proepiregulin | |
Modification date | 20141207 | |
dbXrefs | MIM : 602061 | |
HGNC : HGNC | ||
Ensembl : ENSG00000124882 | ||
HPRD : 03638 | ||
Vega : OTTHUMG00000130005 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_EREG | |
BioGPS: 2069 | ||
Pathway | NCI Pathway Interaction Database: EREG | |
KEGG: EREG | ||
REACTOME: EREG | ||
Pathway Commons: EREG | ||
Context | iHOP: EREG | |
ligand binding site mutation search in PubMed: EREG | ||
UCL Cancer Institute: EREG | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Bone marrowSkin | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | LAMLSKCM | |
Reference showing the relevant tissue of EREG | ||
Description by TissGene annotations | Cancer gene Have significant anti-correlated miRNA |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0007267 | cell-cell signaling | 14581411 | GO:0008284 | positive regulation of cell proliferation | 10681561 | GO:0009299 | mRNA transcription | 10681561 | GO:0019221 | cytokine-mediated signaling pathway | 9419975 | GO:0042108 | positive regulation of cytokine biosynthetic process | 10681561 | GO:0042327 | positive regulation of phosphorylation | 10681561 | GO:0043616 | keratinocyte proliferation | 10681561 | GO:0045740 | positive regulation of DNA replication | 10681561 | GO:0045860 | positive regulation of protein kinase activity | 14581411 | GO:0045892 | negative regulation of transcription, DNA-templated | 14581411 | GO:0048146 | positive regulation of fibroblast proliferation | 12702554 | GO:0051151 | negative regulation of smooth muscle cell differentiation | 14581411 | GO:0007267 | cell-cell signaling | 14581411 | GO:0008284 | positive regulation of cell proliferation | 10681561 | GO:0009299 | mRNA transcription | 10681561 | GO:0019221 | cytokine-mediated signaling pathway | 9419975 | GO:0042108 | positive regulation of cytokine biosynthetic process | 10681561 | GO:0042327 | positive regulation of phosphorylation | 10681561 | GO:0043616 | keratinocyte proliferation | 10681561 | GO:0045740 | positive regulation of DNA replication | 10681561 | GO:0045860 | positive regulation of protein kinase activity | 14581411 | GO:0045892 | negative regulation of transcription, DNA-templated | 14581411 | GO:0048146 | positive regulation of fibroblast proliferation | 12702554 | GO:0051151 | negative regulation of smooth muscle cell differentiation | 14581411 |
Top |
TissGeneExp for EREG |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
BRCA | -1.564265714 | -0.157091153 | -1.407174561 | 1.59E-05 | 3.85E-05 |
THCA | -1.196716309 | -3.229806139 | 2.033089831 | 5.69E-07 | 2.23E-06 |
KIRP | -1.421108258 | -2.509764508 | 1.08865625 | 0.0253 | 0.049975859 |
LIHC | -2.561841258 | -1.434257258 | -1.127584 | 0.0107 | 0.022419528 |
KICH | -3.206517258 | -2.010609258 | -1.195908 | 0.00811 | 0.014870582 |
LUSC | 0.294468703 | 2.118353017 | -1.823884314 | 0.000103 | 0.000213195 |
Top |
TissGene-miRNA for EREG |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
ACC | hsa-miR-130b-3p | MIMAT0000691 | 0.0013 | -0.36 | 78 |
ACC | hsa-miR-130b-3p | MIMAT0000691 | 0.0013 | -0.36 | 78 |
Top |
TissGeneMut for EREG |
TissGeneSNV for EREG |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.R147* | SKCM | 3 |
p.R147X | SKCM | 2 |
p.E155K | SKCM | 2 |
p.G79E | SKCM | 1 |
p.A120S | UCEC | 1 |
p.R6K | SKCM | 1 |
p.R147* | UCEC | 1 |
p.Q53E | LUSC | 1 |
p.R147X | COAD | 1 |
p.V85L | ESCA | 1 |
p.L125R | UCEC | 1 |
p.L26P | LUAD | 1 |
p.S69I | ESCA | 1 |
p.L31F | SKCM | 1 |
p.R145K | READ | 1 |
p.S161* | BLCA | 1 |
p.Q62K | SKCM | 1 |
p.R102L | ESCA | 1 |
p.S161L | LUAD | 1 |
p.A61S | STAD | 1 |
p.Y139S | LUAD | 1 |
p.V110I | HNSC | 1 |
p.S69I | LUAD | 1 |
p.K150I | SKCM | 1 |
p.E8K | LGG | 1 |
Top |
TissGeneCNV for EREG |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for EREG |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for EREG |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for EREG |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for EREG |
TissGeneDrug for EREG |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for EREG |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0027627 | Neoplasm Metastasis | 4 | BeFree |
umls:C0009402 | Colorectal Carcinoma | 3 | BeFree |
umls:C0596263 | Carcinogenesis | 3 | BeFree |
umls:C0948380 | Colorectal cancer metastatic | 3 | BeFree |
umls:C1527249 | Colorectal Cancer | 3 | BeFree |
umls:C0006142 | Malignant neoplasm of breast | 2 | BeFree |
umls:C0007131 | Non-Small Cell Lung Carcinoma | 2 | BeFree |
umls:C0024623 | Malignant neoplasm of stomach | 2 | BeFree |
umls:C0699791 | Stomach Carcinoma | 2 | BeFree |
umls:C2239176 | Liver carcinoma | 2 | BeFree |
umls:C0001418 | Adenocarcinoma | 1 | BeFree |
umls:C0002793 | Anaplasia | 1 | BeFree |
umls:C0003864 | Arthritis | 1 | BeFree |
umls:C0003873 | Rheumatoid Arthritis | 1 | BeFree |
umls:C0007137 | Squamous cell carcinoma | 1 | BeFree,LHGDN |
umls:C0008373 | Cholesteatoma | 1 | BeFree |
umls:C0009319 | Colitis | 1 | BeFree |
umls:C0010606 | Adenoid Cystic Carcinoma | 1 | BeFree |
umls:C0015230 | Exanthema | 1 | BeFree |
umls:C0017636 | Glioblastoma | 1 | BeFree |
umls:C0017638 | Glioma | 1 | BeFree |
umls:C0017661 | IGA Glomerulonephritis | 1 | CTD_human |
umls:C0024121 | Lung Neoplasms | 1 | LHGDN |
umls:C0027809 | Neurilemmoma | 1 | BeFree |
umls:C0029463 | Osteosarcoma | 1 | BeFree |
umls:C0029925 | Ovarian Carcinoma | 1 | BeFree |
umls:C0038356 | Stomach Neoplasms | 1 | BeFree |
umls:C0041296 | Tuberculosis | 1 | BeFree |
umls:C0041327 | Tuberculosis, Pulmonary | 1 | BeFree |
umls:C0152013 | Adenocarcinoma of lung (disorder) | 1 | BeFree |
umls:C0153676 | Secondary malignant neoplasm of lung | 1 | BeFree |
umls:C0153690 | Secondary malignant neoplasm of bone | 1 | BeFree |
umls:C0155490 | Middle Ear Cholesteatoma | 1 | BeFree |
umls:C0162557 | Liver Failure, Acute | 1 | BeFree |
umls:C0162568 | Erythropoietic Protoporphyria | 1 | CTD_human |
umls:C0206698 | Cholangiocarcinoma | 1 | BeFree |
umls:C0238198 | Gastrointestinal Stromal Tumors | 1 | BeFree |
umls:C0334463 | Malignant Fibrous Histiocytoma | 1 | LHGDN |
umls:C0494165 | Secondary malignant neoplasm of liver | 1 | BeFree |
umls:C0520679 | Sleep Apnea, Obstructive | 1 | BeFree |
umls:C0555198 | Malignant Glioma | 1 | BeFree |
umls:C0585442 | Osteosarcoma of bone | 1 | BeFree |
umls:C0919267 | ovarian neoplasm | 1 | CTD_human |
umls:C1140680 | Malignant neoplasm of ovary | 1 | BeFree |
umls:C1167791 | Skin toxicity | 1 | BeFree |
umls:C1263846 | Attention deficit hyperactivity disorder | 1 | GAD |
umls:C1318485 | Liver regeneration disorder | 1 | BeFree |
umls:C1458155 | Mammary Neoplasms | 1 | LHGDN |
umls:C1512981 | Mammary Tumorigenesis | 1 | BeFree |